114 related articles for article (PubMed ID: 28938598)
1. Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer.
Wang X; Liu C; Wang J; Fan Y; Wang Z; Wang Y
Oncotarget; 2017 Aug; 8(35):58801-58808. PubMed ID: 28938598
[TBL] [Abstract][Full Text] [Related]
2. Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer.
Wong GG; Ha V; Chu MP; Dersch-Mills D; Ghosh S; Chambers CR; Sawyer MB
Clin Colorectal Cancer; 2019 Mar; 18(1):72-79. PubMed ID: 30551953
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors and colorectal cancer: A systematic review.
Patel A; Spychalski P; Antoszewska M; Regula J; Kobiela J
World J Gastroenterol; 2021 Nov; 27(44):7716-7733. PubMed ID: 34908809
[TBL] [Abstract][Full Text] [Related]
4. Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy.
Kichenadasse G; Miners JO; Mangoni AA; Karapetis CS; Hopkins AM; Sorich MJ
J Natl Compr Canc Netw; 2021 May; 19(9):1037-1044. PubMed ID: 33951613
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitors Enhance the Antitumor Effect of Chemotherapy for Esophageal Squamous Cell Carcinoma.
Matsumura S; Ishikawa T; Yoshida J; Morita R; Sakakida T; Endo Y; Doi T; Hirose R; Inoue K; Dohi O; Yoshida N; Uchiyama K; Takagi T; Konishi H; Yasui K; Naito Y; Itoh Y
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626000
[TBL] [Abstract][Full Text] [Related]
6. FOLFOX as adjuvant chemotherapy after curative resection of distant metastases in patients with colorectal cancer.
Nozawa H; Kitayama J; Sunami E; Saito S; Kanazawa T; Kazama S; Yazawa K; Kawai K; Mori K; Nagawa H
Oncology; 2011; 80(1-2):84-91. PubMed ID: 21677451
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.
Graham C; Orr C; Bricks CS; Hopman WM; Hammad N; Ramjeesingh R
Curr Oncol; 2016 Dec; 23(6):e583-e588. PubMed ID: 28050148
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of proton pump inhibitors ameliorates nephrotoxicity in patients receiving chemotherapy with cisplatin and fluorouracil: a retrospective cohort study.
Ikemura K; Oshima K; Enokiya T; Okamoto A; Oda H; Mizuno T; Ishinaga H; Muraki Y; Iwamoto T; Takeuchi K; Katayama N; Okuda M
Cancer Chemother Pharmacol; 2017 May; 79(5):943-949. PubMed ID: 28364288
[TBL] [Abstract][Full Text] [Related]
9. Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis.
Lin WY; Wang SS; Kang YN; Porpiglia AS; Chang Y; Huang CH; Bhimani R; Abdul-Lattif E; Azmat M; Wang TH; Lin YS; Chang YC; Chi KY
Front Pharmacol; 2022; 13():1048980. PubMed ID: 36578549
[TBL] [Abstract][Full Text] [Related]
10. Examination of the Effect of Proton Pump Inhibitors on the Anticancer Activity of Oxaliplatin.
Hashizume J; Sato K; Nakagawa H; Harasawa H; Honda T; Kodama Y
Cancer Diagn Progn; 2022; 2(6):620-626. PubMed ID: 36340458
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Proton Pump Inhibitor Use on Survival of Patients With Colorectal Cancer: A Study of a Racially Diverse Population.
Obeidat AE; Monti G; Choi H; Acoba J
Cureus; 2023 May; 15(5):e38707. PubMed ID: 37292522
[TBL] [Abstract][Full Text] [Related]
12. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic Risk lncRNA-PVT1 SNP Sensitizes Metastatic Colorectal Cancer to FOLFOX Regimen.
Wu S; Yang X; Tang W; Familiari G; Relucenti M; Aschner M; Li X; Chen R
Front Oncol; 2022; 12():808889. PubMed ID: 35433465
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
[TBL] [Abstract][Full Text] [Related]
15. [FOLFOX as adjuvant chemotherapy after curative resection of distant metastatic lesions in patients with colorectal cancer].
Nozawa H; Kitayama J; Sunami E; Saito S; Kanazawa T; Kazama S; Yazawa K; Kawai K; Mori K; Nagawa H
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1627-32. PubMed ID: 21996957
[TBL] [Abstract][Full Text] [Related]
16. Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).
Hoff PM; Hochhaus A; Pestalozzi BC; Tebbutt NC; Li J; Kim TW; Koynov KD; Kurteva G; Pintér T; Cheng Y; van Eyll B; Pike L; Fielding A; Robertson JD; Saunders MP
J Clin Oncol; 2012 Oct; 30(29):3596-603. PubMed ID: 22965965
[TBL] [Abstract][Full Text] [Related]
17. Network meta-analysis of Chinese herb injections combined with FOLFOX chemotherapy in the treatment of advanced colorectal cancer.
Ge L; Wang YF; Tian JH; Mao L; Zhang J; Zhang JH; Shen XP; Yang KH
J Clin Pharm Ther; 2016 Aug; 41(4):383-91. PubMed ID: 27338003
[TBL] [Abstract][Full Text] [Related]
18. Demethylzeylasteral inhibits cell proliferation and enhances cell chemosensitivity to 5-fluorouracil in Colorectal Cancer cells.
Yang Y; Han J; Ma Y; Zhang J; Zhang Z; Wang G
J Cancer; 2020; 11(20):6059-6069. PubMed ID: 32922546
[TBL] [Abstract][Full Text] [Related]
19. First-line Treatment of Advanced Biliary Ducts Carcinoma: A Randomized Phase II Study Evaluating 5-FU/LV Plus Oxaliplatin (Folfox 4)
Schinzari G; Rossi E; Mambella G; Strippoli A; Cangiano R; Mutignani M; Basso M; Cassano A; Barone C
Anticancer Res; 2017 Sep; 37(9):5193-5197. PubMed ID: 28870954
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of postoperative oxaliplatin- or irinotecan-based chemotherapy after curative resection of synchronous liver metastases from colorectal cancer.
Hsu HC; Chou WC; Shen WC; Wu CE; Chen JS; Liau CT; Lin YC; Yang TS
Anticancer Res; 2013 Aug; 33(8):3317-25. PubMed ID: 23898098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
